Should I Buy EZRA? EZRA 2026 Analysis

Should You Buy Reliance Global Group Inc (EZRA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

0.230

1 Day change

42.59%

52 Week Range

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now: today’s -6.07% regular-session drop with no proprietary buy signals suggests weak near-term demand.
Fundamentals are still deteriorating in key areas (revenue, EPS, gross margin), which matters more than the positive operational headlines.
News flow is constructive (premium and partner growth), but it has not translated into price strength; for an impatient buyer, this setup is unfavorable.

Technical Analysis

Trend data was not provided, so analysis relies on the latest price action: the stock sold off sharply in the regular session (-6.07%) and did not meaningfully rebound post-market (-0.17%), indicating bearish momentum into the close.
Microcap/penny-stock price level (~$0.18) typically implies elevated volatility and frequent liquidity-driven moves; without a confirmed reversal signal, chasing here is not attractive.

Intellectia Proprietary Trading Signals

AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Positive Catalysts

- Written premium for RELI Exchange Personal Lines P&C grew ~36% (2024: $11.47M to 2025: $15.6M), signaling improving top-of-funnel insurance activity.
- Agency partners expanded meaningfully (about 65 to ~300 since 2022), suggesting distribution scale-up.
- Strategy to seek strategic investments in high-growth technology firms (EZRA International Group) could create event-driven upside if a credible deal is announced.

Neutral/Negative Catalysts

- Market is rejecting the stock near-term (sharp down day), which can overwhelm positive headlines.
- Trading trends show no supportive accumulation: hedge funds neutral (no significant trends last quarter) and insiders neutral (no significant trends last month).
- No recent congress trading data available (no influential/political confirmation catalyst).

Financial Performance

Latest quarter provided: 2025/Q3.
Revenue: $2,495,975, down -27.47% YoY (clear top-line contraction).
Net income: -$1,156,583 (still a loss) but improved +38.13% YoY.
EPS: -0.20, down -70.15% YoY (worsening per-share performance).
Gross margin: 47.53%, down -22.75% YoY (profitability pressure).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating/price target change data was provided, so a current Wall Street consensus (pros/cons, upgrades/downgrades) cannot be verified from the dataset.
With no observable Street support in the provided data and weak near-term price action, the practical pro view is limited to operational growth headlines, while the con view is driven by shrinking revenue, weaker EPS, and margin deterioration.

0 Analyst Rating

Wall Street analysts forecast EZRA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EZRA is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

0 Hold

0 Sell

Current: 0.162

Low

Averages

High